2011

• February 18

  NIH Approves Rapid Access Funding of EDN-OL1

2009

• February 1

  Publication of Results for Edunn's Second Antisense Drug

• January 15

  Alzheimer's Drug Discovery Foundation Funds Edunn Biotechnology to Develop Treatment for Alzheimer's Disease

2008

• November 15

  Dr. Thomas Darling Speaks at Alzheimer's Conference

Dr. Thomas Darling Speaks at 5th International Winter-Conference on Alzheimer's Disease

Zurich, Austria (November 15, 2008) - Dr. Darling was an invited guest speaker at 5th International Winter-Conference on Alzheimer's Disease, December 6tth through 9th, 2008, at Zurs, Austria. The Conference was organized by the Austrian Society for Alzheimer Disease. His presentation was titled: "Antisense Oligonucleotides as a New Class of CNS Drugs."